MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, SBFMW has $31,487,379 in assets. $7,288,023 in debts.

Balance Sheets Overview

Current Ratio
420.48%
Quick Ratio
209.03%
Debt to Asset Ratio
23.15%
Assets Breakdown
    • Inventory
    • Cash and cash equivalents
    • Accounts receivable
    • Others
Liabilities Breakdown
    • Capital paid in excess of par va...
    • Accumulated (deficit)
    • Accounts payable & accrued expen...
    • Others

Unit: Dollar
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
9,306,438 10,305,320
Accounts receivable
4,155,599 3,587,560
Inventory
14,063,706 13,018,702
Prepaid expenses
441,489 939,436
Total current assets
27,967,232 27,851,018
Total
1,060,556 -
Less accumulated depreciation
462,469 -
Property & equipment
598,087 638,354
Intangible assets
2,009,337 2,490,827
Deferred tax asset
92,234 92,234
Right-of-use-asset
820,489 892,817
Total long-term assets
3,520,147 4,114,232
Total assets
31,487,379 31,965,250
Accounts payable & accrued expenses
6,137,465 4,797,465
Earnout payable
295,797 295,797
Income tax payable
0 258,158
Right-of-use-liability
218,053 222,496
Total current liabilities
6,651,315 5,573,916
Right-of-use-liability
636,708 706,530
Total long-term liabilities
636,708 706,530
Total liabilities
7,288,023 6,280,446
Preferred stock series b 0.10 par value per share 1,000,000 shares authorized 130,000 shares issued and outstanding
13,000 13,000
Common stock 0.001 par value per share 3,000,000,000 shares authorized 4,555,945 and 2,580,098 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively
4,555 4,555
Capital paid in excess of par value
97,376,841 97,376,841
Accumulated comprehensive income
-320,841 280,787
Accumulated (deficit)
-72,874,199 -71,990,379
Total shareholders' equity
24,199,356 25,684,804
Total liabilities and shareholders' equity
31,487,379 31,965,250
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Total$1,060,556 Right-of-use-asset$820,489 Deferred tax asset$92,234 Intangible assets$2,009,337 Property & equipment$598,087 Prepaid expenses$441,489 Inventory$14,063,706 Accounts receivable$4,155,599 Cash and cashequivalents$9,306,438 Less accumulateddepreciation$462,469 Total long-termassets$3,520,147 Total current assets$27,967,232 Total assets$31,487,379 Total liabilities andshareholders' equity$31,487,379 Total shareholders'equity$24,199,356 Total liabilities$7,288,023 Accumulated (deficit)-$72,874,199 Accumulated comprehensiveincome-$320,841 Capital paid in excess ofpar value$97,376,841 Total long-termliabilities$636,708 Total currentliabilities$6,651,315 Common stock 0.001 parvalue per share...$4,555 Preferred stock series b0.10 par value per...$13,000 Right-of-use-liability$636,708 Right-of-use-liability$218,053 Earnout payable$295,797 Accounts payable &accrued expenses$6,137,465

Sunshine Biopharma Inc. (SBFMW)

Sunshine Biopharma Inc. (SBFMW)